This is the authors' abstract. We don't add key points for this paper.
variants had abnormal mucocutaneous, surgical, and dental bleeding from childhood, requiring ≥1 blood or platelet transfusion in 78% of cases. Platelets displayed reduced aggregation in response to adenosine 5'-diphosphate and epinephrine, but variable aggregation defects with other agonists. There were no other consistent clinical or laboratory features. These data enable definition of human CalDAG-GEFI deficiency as a nonsyndromic, recessive PFD associated with a moderate or severe bleeding phenotype and complex defects in platelet aggregation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Westbury et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: